awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q41386664-0F78410B-96F3-4ED1-BB1A-A70940079FA7
Q41386664-0F78410B-96F3-4ED1-BB1A-A70940079FA7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41386664-0F78410B-96F3-4ED1-BB1A-A70940079FA7
Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads.
P2093
Q41386664-0F78410B-96F3-4ED1-BB1A-A70940079FA7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41386664-0F78410B-96F3-4ED1-BB1A-A70940079FA7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
80010b3a2d7be4b4b250900102dbb38e12bd458a
P1545
12
http://www.w3.org/2001/XMLSchema#string
P2093
Angelo Ghezzi
http://www.w3.org/2001/XMLSchema#string